Journal
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY
Volume 47, Issue 5, Pages 424-443Publisher
TAYLOR & FRANCIS LTD
DOI: 10.3109/10409238.2012.694844
Keywords
IL-1 beta; inflammasome; AIM2; NLRP3
Categories
Funding
- Science Foundation Ireland
Ask authors/readers for more resources
The extensively studied cytokine IL-1 beta is an important mediator of the inflammatory response. However, dysregulated release of IL-1 beta can be detrimental and is attributed to the progression and pathogenesis of multiple inflammatory diseases including, rhuematoid arthritis (RA), atherosclerosis, type 2 diabetes (T2D), Alzheimers disease and gout. IL-1 beta is encoded as a pro-protein. A multi-protein molecular scaffold termed the Inflammasome is responsible for the tightly controlled and coordinated processing of pro-IL-1 beta. The activation of several NLR (nucleotide-binding oligomerization domain (NOD)-like receptor) family members and PYHIN (pyrin and HIN domain) proteins can drive the formation of inflammasomes. However, the exact biochemical mechanisms governing their activation have been the subject of much research. Different inflammasomes have been demonstrated to respond to the same pathogen inducing a cooperative immune response accountable for the clearance of infection. Here, we review current knowledge surrounding the biochemical regulation of the NLRP1, NLRP3, NLRC4, AIM2 and IFI16 inflammasomes.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available